Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Roskilde
Clinical trial register · Denmark

Clinical Trials in Roskilde, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Zealand University Hospital18 Copenhagen University Hospital, Rigshospitalet8 AbbVie7 AstraZeneca6 Boehringer Ingelheim6
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Roskilde

148 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
NCT07842198Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM), Gut Microbiota
DrugsCeftazidime·Ciprofloxacin
Zealand University Hospital
Phase 2
150
Roskilde
2027-03-01
Not yet open
Anne Louise Tølbøll Sørensen
Phase 4
400
Copenhagen, Aalborg, Aarhus, Odense, Roskilde
2027-03
Not yet open
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
NCT07200739Dementia (Diagnosis), Alzheimer Dementia (AD), Vascular Dementia (VaD), Lewy Body Dementia (LBD)
Zealand University Hospital
Observational
440
Roskilde
2026-11-01
Recruiting
CSL Behring
Phase 3
63
Vejle, Copenhagen, Roskilde
2026-09-15
Not yet open
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors
NCT07762820Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1
Ludwig-Maximilians - University of Munich
Not applicable
75
Aarhus, Roskilde
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Roskilde
2026-08-21
Recruiting
Eli Lilly and Company
Phase 2
606
Aalborg, Aarhus, Copenhagen, Hvidovre, Roskilde, Vejle
2026-08-07
Not yet open
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
NCT07634263Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple Myeloma Refractory
Odense University Hospital
Observational
50
Copenhagen, Odense, Roskilde
2026-07-01
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Metabolic Control in Anesthesia and Surgery
NCT07573930Anesthesia, Continuous Glucose Monitoring, Hyperglycemia Steroid-induced, Hyperglycemia Stress
Zealand University Hospital
Observational
100
Roskilde
2026-04-23
Not yet open
Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI Model
NCT07461324Postoperative Infections, Mandibular Nerve Injuries, Alveolar Osteitis, Complication
University of Copenhagen
Observational
3,000
Copenhagen, Roskilde
2026-04-01
Recruiting
Boehringer Ingelheim
Phase 2
132
Roskilde
2026-03-23
Recruiting
Incyte Corporation
Phase 3
700
Aalborg, Odense C, Roskilde, Vejle
2026-03-05
Recruiting
Boehringer Ingelheim
Phase 3
286
København Ø, Roskilde
2026-02-16
Recruiting
Assessment of Residual Congestion in Acute Decompensated Heart Failure
NCT07682298Acute Heart Failure (AHF), Decompensated Chronic Heart Failure
Aarhus University Hospital
Observational
580
Aarhus, Copenhagen, Roskilde
2026-02-15
Recruiting
Boehringer Ingelheim
Phase 3
400
Roskilde
2026-01-16
Recruiting
Zealand University Hospital
Not applicable
20
Copenhagen, Roskilde
2025-12-01
Recruiting
Zealand University Hospital
Observational
2,500
Aarhus N, Herlev, København Ø, Roskilde
2025-11-26
Recruiting
Aarhus University Hospital
Phase 3
1,652
Aalborg, Aarhus, Copenhagen, Herlev, Herning, Kolding, Odense, Roskilde
2025-11-26
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Aalborg, Aarhus N, København Ø, Odense, Roskilde
2025-11-23
Recruiting
AstraZeneca
Phase 2
435
Aalborg, Aarhus N, Hvidovre, Odense C, Roskilde
2025-11-06
Recruiting
Pfizer
Phase 3
680
Copenhagen, Roskilde, Odense, Aarhus N
2025-09-29
Recruiting
The Post-ICU Pain Study
NCT07180407Chronic Pain, Post Intensive Care Unit Syndrome, Quality of Life, Pain Disorder
Zealand University Hospital
Observational
800
Aalborg, Køge, Nykøbing Falster, Roskilde
2025-09-23
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Aalborg, Aarhus N, Copenhagen, Odense, Roskilde
2025-08-05
Recruiting
University of Southern Denmark
Not applicable
30
Aalborg, Aarhus, Roskilde
2025-07-04
Recruiting
AstraZeneca
Phase 2
987
Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
2025-06-27
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Aarhus N, Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
2025-06-25
Recruiting
GlaxoSmithKline
Phase 3
981
Roskilde, Aalborg, Hvidovre
2025-06-20
Recruiting
BeOne Medicines
Phase 3
630
Aalborg, Copenhagen, Odense, Roskilde
2025-06-11
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Aalborg, Copenhagen, Odense, Roskilde
2025-06-04
Recruiting
Jakob Kristian Jakobsen
Phase 4
272
Aalborg, Aarhus N, Herlev, Roskilde
2025-06-01
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Aabenraa, Copenhagen, Copenhagen NV, Copenhagen S, Herlev, Holbæk, Hvidovre, Roskilde
2025-05-20
Recruiting
Copenhagen University Hospital, Rigshospitalet
Not applicable
150
Copenhagen, Herlev, Hillerød, Roskilde
2025-05-16
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Aalborg, Aarhus, Hellerup, København NV, Odense, Roskilde
2025-04-15
Recruiting
My Avenue to helP - Adaptive Mentalization-based Integrative Treatment Compared to Management as Usual for Youths With Multiple Problems: a Non-Randomized Controlled Feasibility Trial
NCT06886165Mental Health Care, AMBIT, Adaptive Mentalization-Based Integrative Treatment, Child and Adolescent Psychiatry
Pia Jeppesen
Not applicable
60
Roskilde
2025-03-25
Recruiting
Daiichi Sankyo
Phase 3
582
Aarhus, Copenhagen, Roskilde
2025-03-19
By invitation
Zealand University Hospital
Not applicable
10
Roskilde
2025-03-19
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Copenhagen, Aarhus, Roskilde, Odense
2025-03-12
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Roskilde
2025-01-31
Recruiting
Pfizer
Phase 3
2,330
Copenhagen, Hilleroed, Herning, Roskilde, Gistrup
2024-12-08
Recruiting
Olav Schjørring
Not applicable
88
Aalborg, Copenhagen, Hillerød, Kolding, Køge, Roskilde
2024-12-02
Active, closed
Continuous Glucose Monitoring in Dialysis Patients With Diabetes
NCT06641765Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis
Bo Feldt-Rasmussen
Not applicable
96
Copenhagen, Herlev, Hillerød, Holbæk, Roskilde
2024-11-01
Recruiting
The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
NCT06647342Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor, Bleomycin Adverse Reaction, Electrochemotherapy
DrugBleomycin
Julie Gehl
Phase 4
55
Herlev, Roskilde
2024-10-29
Recruiting
Zealand University Hospital
Not applicable
72
Roskilde
2024-10-24
Recruiting
Herlev and Gentofte Hospital
Phase 4
17,200
Copenhagen, Herlev, Hillerød, Holbæk, Hvidovre, Køge, Nykøbing Falster, Roskilde
2024-10-10
By invitation
Odense University Hospital
Phase 2/3
80
Odense, Roskilde, Vejle
2024-09-09
Recruiting
Johannes Grand
Phase 4
939
Hvidovre, Aarhus, Copenhagen, Roskilde
2024-09-05
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Aalborg, Copenhagen, Herlev, Kolding, Odense, Roskilde
2024-08-30
Recruiting
Aalborg University Hospital
Not applicable
1,616
Aalborg, Aarhus, Copenhagen, Hellerup, Odense, Roskilde
2024-08-28
Recruiting
AstraZeneca
Phase 3
1,018
Aalborg, Copenhagen, Odense C, Roskilde
2024-08-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Copenhagen, Aarhus, Roskilde, Odense C
2024-07-16
Active, closed
AbbVie
Phase 3
1,400
Hellerup, Aarhus, Roskilde
2024-06-27
By invitation
Zealand University Hospital
Not applicable
362
Næstved, Odense, Roskilde
2024-05-07
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Aarhus, Copenhagen, Herlev, Odense, Roskilde
2024-04-18
Recruiting
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
NCT06356779Oligometastatic Disease, Metastases, Ablation Techniques, Radiotherapy
Gitte Fredberg Persson MD PhD
Not applicable
1,200
Copenhagen, Herlev, Hillerød, Aarhus, Herning, Aalborg, Roskilde, Odense
2024-04-15
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Esbjerg, Hvidovre, Roskilde, Viborg
2024-03-07
Recruiting
TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
NCT07716969Psychosis, Schizo Affective Disorder, SCHIZOPHRENIA 1 (Disorder)
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Observational
250
Copenhagen, Roskilde
2024-03-01
Active, closed
Genmab
Phase 3
1,095
Copenhagen Ø, Herning, Roskilde, Odense, Vejle
2024-02-05
Active, closed
Copenhagen University Hospital, Rigshospitalet
Observational
214
Copenhagen, Herlev, Roskilde
2024-02-02
Active, closed
Incyte Corporation
Phase 3
617
Århus N, Roskilde
2024-01-30
Recruiting
Eli Lilly and Company
Phase 3
1,264
Roskilde
2023-12-21
Active, closed
Xentria, Inc.
Phase 1/2
32
Aalborg, Aarhus, Odense, Roskilde, Vejle
2023-11-10
Active, closed
AstraZeneca
Phase 3
1,835
Aalborg, Aarhus, Herlev, Herning, Roskilde
2023-11-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Copenhagen, Herlev, Aarhus, Herning, Gandrup, Hjørring, Roskilde, Slagelse
2023-10-09
Active, closed
Incyte Corporation
Phase 1
160
Roskilde, Vejle
2023-09-25
Recruiting
DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure
NCT05276219Pulmonary Edema, Congestive Heart Failure, Acute Heart Failure
DrugFurosemide
Copenhagen University Hospital, Rigshospitalet
Phase 4
1,041
Copenhagen, Herlev, Hillerød, Roskilde
2023-09-14
Active, closed
Boehringer Ingelheim
Phase 2
268
Aalborg, Hvidovre, København Ø, Odense, Roskilde, Vejle
2023-09-08
Not yet open
Copenhagen University Hospital at Herlev
Observational
1,500
Herlev, Aalborg, Aarhus, Odense, Roskilde
2023-09-01
Recruiting
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
NCT05889247Non-small Cell Lung Cancer Metastatic
Zealand University Hospital
Not applicable
350
Hillerød, Næstved, Roskilde, Aalborg, Vejle
2023-07-28
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Aalborg, Hellerup, Hvidovre, Odense C, Roskilde, Vejle
2023-06-28
Recruiting
The Liver Care Trial
NCT05855031Alcoholic Liver Disease, Alcohol Use Disorder, Alcohol Abuse, Alcoholism
Zealand University Hospital
Not applicable
408
Køge, Roskilde
2023-05-08
Recruiting
University of Southern Denmark
Not applicable
280
Aabenraa, Aalborg, Aarhus, Hellerup, Odense, Roskilde
2023-03-13
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Aarhus N, Copenhagen S, Esbjerg, Gandrup, Herlev, Herning, Kobenhavn N V, Roskilde
2023-03-09
Active, closed
Genmab
Phase 3
900
Copenhagen Ø, Aarhus, Roskilde, Odense, Vejle
2023-02-08
Recruiting
Odense University Hospital
Phase 2
39
Aalborg, Aarhus, Copenhagen, Odense, Roskilde
2023-02-01
Recruiting
Odense University Hospital
Not applicable
300
Odense, Vejle, Roskilde, Copenhagen, Herlev
2023-02-01
Active, closed
Bristol-Myers Squibb
Phase 3
606
Aarhus, Roskilde, Odense, Vejle
2023-01-10
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Næstved, Roskilde
2022-12-29
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Aalborg, Aarhus, Roskilde
2022-12-14
Recruiting
INfluenza VaccInation To Mitigate typE 1 Diabetes
NCT05585983Diabetes Mellitus, Type 1
Aarhus University Hospital
Phase 4
100
Aalborg, Aarhus, Copenhagen, Herning, Holbæk, Nykøbing Falster, Randers, Roskilde
2022-12-14
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Aalborg, Glostrup Municipality, Roskilde
2022-11-21
Recruiting
Copenhagen University Hospital, Rigshospitalet
Not applicable
220
Copenhagen, Gentofte Municipality, Roskilde
2022-10-27
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Aalborg, Herning, Roskilde, Vejle
2022-10-25
Recruiting
Zealand University Hospital
Not applicable
62
Roskilde
2022-09-20
Recruiting
Morten Steen Kvistholm Jensen
Phase 4
100
Aarhus N, Odense, Roskilde, Viborg
2022-08-10
Recruiting
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
NCT05444348Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Myeloid Leukemia
Christoffer Johansen
Not applicable
920
Aalborg, Aarhus, Esbjerg, Herning, Odense, Roskilde, Vejle
2022-08-01
Active, closed
Celgene
Phase 3
939
Aalborg, Odense, Roskilde
2022-06-23
Recruiting
Rikke Sorensen
Phase 4
2,808
Aalborg, Copenhagen, Hellerup, Odense, Roskilde, Skejby
2022-06-17
Recruiting
AbbVie
Phase 3
768
Roskilde, Odense
2022-03-25
Active, closed
HIFU for Treatment of Non-nodular and Recurrent BCC
NCT05133427Carcinoma, Basal Cell
Joergen Serup
Not applicable
40
Copenhagen, Roskilde
2022-03-21
Recruiting
The Organ Transplant Recipient HPV and Skin Cancer Study
NCT05284877Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection
Merete Haedersdal
Observational
1,500
Copenhagen NV, Hellerup, Roskilde
2022-03-10
Recruiting
Zealand University Hospital
Not applicable
250
Aalborg, Herning, Odense, Roskilde, Sønderborg, Vejle
2022-03-01
Recruiting
Zealand University Hospital
Not applicable
800
Copenhagen, Hillerød, Aarhus, Aalborg, Roskilde, Odense
2022-02-14
Recruiting
University of Southern Denmark
Phase 3
140
Aarhus, Copenhagen, Herlev, Odense, Roskilde
2022-02-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Copenhagen, Aalborg, Roskilde
2022-02-03
Active, closed
TEENS Multi-site Trial
NCT05179655Self-Injurious Behavior
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Not applicable
363
Aalborg, Odense, Roskilde, Copenhagen
2022-02-01
Active, closed
Nordic Lymphoma Group
Phase 2
81
Odense, Roskilde
2021-12-15
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Herning, Aarhus N, Esbjerg, Glostrup Municipality, Herlev, Hjørring, Roskilde, Svendborg
2021-11-23
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Aarhus, Esbjerg, Gistrup, Hellerup, Herning, Odense, Roskilde, Svendborg
2021-08-14
Recruiting
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
NCT04916132Chronic Kidney Diseases, Albuminuria, Diabetic Kidney Disease, Diabetic Nephropathies
Herlev Hospital
Observational
300
Skejby, Copenhagen, Hillerød, Holbæk, Køge, Nykøbing Falster, Roskilde, Slagelse
2021-08-10
Recruiting
Renal Cancer Detection With Liquid Biopsy
NCT05060783Renal Cancer, Oncocytoma
Zealand University Hospital
Observational
200
Roskilde
2021-07-01
Active, closed
Incyte Corporation
Phase 3
654
Aalborg, Aarhus, Odense, Roskilde
2021-04-15
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Aarhus N, Aalborg, Roskilde, Odense C
2021-04-05
Active, closed
German CLL Study Group
Phase 3
897
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2021-03-01
Active, closed
Shanghai MicroPort Medical (Group) Co., Ltd.
Not applicable
1,720
Aarhus, Copenhagen, Odense, Roskilde
2021-02-17
Active, closed
NORTH-REG Dwell-Time Study
NCT04701151Side Effect of Drug
DrugBacillus Calmette-Guerin
Jørgen Bjerggaard Jensen
Phase 4
314
Aarhus, Aalborg, Copenhagen, Herlev, Herning, Odense, Roskilde
2021-02-03
Active, closed
Local Antibiotics for Breast Implants
NCT04731025Implant Complication, Implant Infection, Implant Site Infection, Implant Capsular Contracture
Mikkel Herly
Phase 3
1,003
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Roskilde, Vejle
2021-01-27
Active, closed
Genmab
Phase 3
483
Aalborg, Aarhus, Roskilde, Vejle
2021-01-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Copehagen, Herlev, Aalborg, Roskilde, Odense
2021-01-10
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Aalborg, Herlev, Odense, Roskilde
2020-12-29
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Copenhagen, Aalborg, Aarhus, Odense, Roskilde, Vejle
2020-11-25
Active, closed
AbbVie
Phase 3
330
Aalborg, Roskilde
2020-08-31
Recruiting
Ulrik Lassen
Phase 2
300
Aalborg, Aarhus, Copenhagen, Herlev, Odense, Roskilde, Vejle
2020-08-24
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Aalborg, Aarhus N, Copenhagen, Roskilde
2020-08-20
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2020-08-19
Active, closed
Incyte Corporation
Phase 2
112
Århus N, Copenhagen, Roskilde
2020-08-03
Active, closed
Sanofi
Phase 3
337
Aalborg, Aarhus N, Copenhagen, Roskilde
2020-06-16
Recruiting
Zealand University Hospital
Not applicable
28
Roskilde
2020-05-01
Recruiting
Zealand University Hospital
Not applicable
60
Roskilde
2020-04-15
Recruiting
Vejle Hospital
Phase 3
162
Aalborg, Copenhagen, Næstved, Roskilde, Vejle
2020-01-20
Recruiting
Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
NCT03730922Breast Neoplasm Female, Complication of Radiation Therapy, Breast Implant; Complications
Danish Breast Cancer Cooperative Group
Not applicable
590
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Roskilde, Vejle, Viborg
2020-01-01
Active, closed
Jørgen Bjerggaard Jensen
Not applicable
392
Holstebro, Århus N, Roskilde
2019-11-01
Recruiting
Copenhagen University Hospital, Rigshospitalet
Phase 2/3
212
Copenhagen, Herlev, Roskilde
2019-10-11
Recruiting
Combining Active and Passive DNA Hypomethylation
NCT03999723Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
Kirsten Grønbæk
Phase 2
196
Aalborg, Aarhus, Copenhagen, Odense, Roskilde
2019-09-11
Active, closed
Tesaro, Inc.
Phase 3
785
Aalborg, Copenhagen, Herlev, Odense C, Roskilde
2019-07-18
Active, closed
Targeted Potassium Levels for Prevention of ICD Therapy
NCT03833089Ventricular Arrhythmias and Cardiac Arrest, Implantable Defibrillator User, Hypokalemia, Hyperkalemia
Copenhagen University Hospital, Rigshospitalet
Phase 4
1,200
Gentofte Municipality, Roskilde, Copenhagen
2019-03-01
Active, closed
Novartis Pharmaceuticals
Phase 2
248
Copenhagen, Roskilde
2019-02-27
Active, closed
Acerta Pharma BV
Phase 3
984
Aarhus, Copenhagen, Roskilde
2019-02-25
Recruiting
Zealand University Hospital
Observational
120
Roskilde
2019-02-01
Recruiting
Nessn Azawi
Observational
5,000
Roskilde
2019-02-01
Active, closed
Accelerated Treatment of Endocarditis
NCT05144399Endocarditis
Herlev Hospital
Not applicable
508
Aarhus, Copenhagen, Gødstrup, Herlev, Hillerød, Hvidovre, Odense, Roskilde
2019-01-17
Active, closed
Accelerated Treatment of Endocarditis
NCT03851575Infectious Endocarditis
Copenhagen University Hospital, Rigshospitalet
Not applicable
508
Copenhagen, Aarhus, Gødstrup, Hillerød, Hvidovre, Odense, Roskilde, Vejle
2019-01-17
Active, closed
AstraZeneca
Phase 3
1,407
Aalborg, Aarhus N, Odense, Roskilde, Vejle
2019-01-04
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Aarhus N, Copenhagen, Hellerup, Odense, Roskilde
2018-11-06
Active, closed
AbbVie
Phase 3
265
Herlev, Aalborg, Odense, Vejle, Roskilde
2018-10-22
Active, closed
Tesaro, Inc.
Phase 3
1,400
Copenhagen, Herlev, Roskilde
2018-10-11
Active, closed
AbbVie
Phase 3
1,242
Copenhagen NV, Hvidovre, Roskilde, Odense C
2018-08-28
Recruiting
Celgene
Phase 2/3
1,541
Roskilde, Aarhus, Odense
2018-07-19
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Aalborg, Aarhus, Copenhagen, Odense C, Roskilde
2018-04-17
Active, closed
AbbVie
Phase 3
1,336
Hvidovre, Aarhus, Roskilde, Nyborg, Odense
2018-04-09
Active, closed
AbbVie
Phase 3
747
Herlev, Hilleroed, Hvidovre, Roskilde
2018-03-21
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Aalborg, Aarhus N, Gentofte Municipality, København Ø, Odense, Roskilde
2017-07-05
Active, closed
Haukeland University Hospital
Observational
3,417
Copenhagen, Odense, Roskilde
2017-06-12
Active, closed
Aarhus University Hospital Skejby
Not applicable
120
Aarhus N, Odense, Roskilde
2016-01
Recruiting
Central Nervous System Infections in Denmark
NCT03418441Central Nervous System Infections, Bacterial Meningitis, Viral Meningitis, Aseptic Meningitis
Aalborg University Hospital
Observational
1,900
Aalborg, Aarhus, Copenhagen, Hillerød, Hvidovre, Odense, Roskilde
2015-01-01
Active, closed
Eli Lilly and Company
Phase 3
669
Copenhagen, Aalborg, Roskilde
2014-07-22
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Aalborg C, Copenhagen, Odense, Roskilde
2013-10-14
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Copenhagen, Hillerød, Hvidovre, Odense, Roskilde, Skejby
1994-01
Rows per page Showing 1–148 of 148
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/roskilde

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 148 of those studies with a site in Roskilde.

How many clinical trials are recruiting in Roskilde?

76 of the 148 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 7 have not yet opened recruitment, 59 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Roskilde), 148 studies
PhaseStudiesRecruitingShare
Phase 3632542.6%
Not applicable342123%
Observational191112.8%
Phase 215910.1%
Phase 41187.4%
Phase 2/3322%
Phase 1/2201.4%
Phase 1100.7%

Most active sponsors

Lead sponsors with the most studies (Roskilde)
Lead sponsorStudiesRecruiting
Zealand University Hospital1814
Copenhagen University Hospital, Rigshospitalet84
AbbVie71
AstraZeneca64
Boehringer Ingelheim64
Novartis Pharmaceuticals61
Incyte Corporation51
Janssen Research & Development, LLC53
Merck Sharp & Dohme LLC51
Aarhus University Hospital Skejby41
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.